Oliza Tablets

Olanzapine Tablets (Oliza) - Product Information

Oliza tablets (Generic Olanzapine 2.5 mg, 5 mg, 7.5 mg & 10 mg) belongs to class of medications known as antipsychotics. Olanzapine tablets are used for the treatment of mental illness such as bipolar disorder, depression, and schizophrenia in adults and adolescents who are at least 13 years old.
Oliza tablets also lessen the incidence of manic episodes in bipolar disorder patients which is characterized by periods of excitement and euphoria. Treatment with Olanzapine tablets is also recommended for the treatment of schizophrenia symptoms such as hallucinations, unusual suspicions, depression, and social anxiety.
Olanzapine tablets work by altering the balance of chemicals such as neurotransmitters in the brain. Olanzapine tablets may be used as the single mode of therapy or in combination with other antipsychotic drugs or antidepressants.
In our online pharmacy, Oliza tablets (Olanzapine) manufactured by Intas Pharmaceuticals Limited, India, are available in the strength of 2.5 mg, 5 mg, 7.5 mg, and 10 mg of Olanzapine.
We also have in stock Generic Aripiprazole Tablets (Asprito) which are prescribed as oral therapy for the effective treatment of psychotic conditions such as schizophrenia and specific symptoms of bipolar disorder (manic depression) in adults and adolescents who are at least 15 years old.

Name of the Drug

Oliza tablets.
Oliza tablets are also available under different brand names such as Joyzol, Olan, Olandus, Olanex, Olanzotic, Olexar, Oleanz, Onza, Ozace, Ozapin Mid, Psycholanz, Psychozap, and Zypine. Oliza tablets are also known as Generic Olanzapine tablets.

Manufacturer of Oliza Tablets

Oliza tablets, available in our online pharmacy are manufactured by Intas Pharmaceuticals Limited, India  
Website: www.intaspharma.com

Active Pharmaceutical Ingredient

The active ingredient present in Oliza tablets is Olanzapine. Each Oliza tablet contains 2.5 mg, 5 mg, 7.5 mg, or 10 mg of Olanzapine.

Oliza Tablets Indications - What is Olanzapine Used For?

Oliza tablets, manufactured by Intas Pharmaceuticals Limited, India in strengths of 2.5 mg, 5 mg, 7.5 mg, and 10 mg, are commonly used as oral therapy for the treatment of mental disorders such as schizophrenia and bipolar disorder.
Oliza tablets belong to a class of medications known as antipsychotics, which modifies the balance of neurotransmitters such as dopamine and serotonin in the brain.
Olanzapine is used to treat schizophrenia. It may also be used alone or with other medicines (eg, lithium or valproate) to treat mania or mixed episodes that is part of bipolar disorder (manic-depressive illness). Olanzapine may also be used together with fluoxetine to treat depression that is a part of bipolar disorder, and depression in patients who received other antidepressants that did not work well.
Olanzapine tablets are prescribed as oral therapy for the treatment of Asperger Syndrome, obsessive compulsive disorder, paranoid disorder, and schizoaffective disorder.
This medicine should not be used to treat behavioral problems in older adult patients who have dementia or Alzheimer's disease.

Generic Olanzapine Dosage - How to Take Oliza Tablets?

Olanzapine tablets should be administered exactly as suggested by your doctor. Your doctor may recommend a dosage of Oliza tablets depending on your age, medical requirement, body weight, other medical conditions, and current medications. Olanzapine tablets should be swallowed with a glass of water. Olanzapine tablets can be administered either before or after a meal. The recommended dosage of Olanzapine tablets is 5 mg to 20 mg per day, administered as a single dose.
To decrease the risk of side effects, your doctor may start your treatment course by recommending a low dosage level and slowly increase it to the most effective dosage. Your doctor may alter the dosage of Oliza tablets depending on your response to treatment and the severity of the medical condition. Oliza tablets work effectively if the amount of the Olanzapine is maintained at a constant level in the body. You should be systematic about the daily schedule for the medication such that you take Olanzapine tablets at about the same time every day, to get the maximum benefit of the medication. During the course of Oliza treatment, patients should keep their bodies adequately hydrated by drinking plenty of water and other oral fluids.
Continue taking Olanzapine tablets without missing any doses for the recommended treatment period and do not stop the treatment suddenly even if you feel better. Abrupt discontinuation of Olanzapine tablets may result in withdrawal symptoms such as sweating, insomnia, tremor, anxiety or nausea and vomiting might occur.
Towards the end of the treatment with Olanzapine tablets, your doctor will gradually decrease the dosage to avoid these undesirable withdrawal symptoms. In case of an overdose of Olanzapine tablets, please seek emergency help. The symptoms of an overdose of Olanzapine tablets include drowsiness, agitation, aggression, slurred speech, confusion, increased heart rate, jerky or uncontrolled muscle movements, trouble breathing, or fainting.
Olanzapine Tablets for Bipolar Disorder
The initial recommended dosage of Olanzapine tablets for the treatment of Bipolar disorder is 10 mg to 15 mg, administered as a single dose. The maintenance dosage of Olanzapine tablets for bipolar disorder patients is 5 mg to 20 mg, administered as a single dose. The maximum recommended dosage of Oliza tablets for the treatment of bipolar disorder is 20 mg, administered as a single dose. Olanzapine tablets may be administered as monotherapy or in combination with other antidepressants such as lithium or valproate.
Olanzapine Tablets for Schizophrenia
The initial recommended dosage of Olanzapine tablets for the treatment of Schizophrenia is 5 mg 5 to 10 mg, administered as a single dose. The maintenance dosage of Oliza tablets for Schizophrenia patients is 10 mg, administered as a single dose. The maximum recommended dosage of Olanzapine tablets for the treatment of Schizophrenia is 20 mg, administered as a single dose.  
Please consult your doctor for exact dosing instructions. Oliza tablets (Generic Olanzapine tablets) should be administered in the dose prescribed by the doctor and for the duration recommended by the doctor.

Missed Dose

If you miss your regular dose of Olanzapine tablets, take it as soon as you remember. You can continue your regular schedule the next day.
If you remember the missed Olanzapine tablets the next day, take your regular dose and skip the missed dose. Do not take a double dose to compensate the missed dose of Olanzapine tablets.

Olanzapine Mechanism of Action - How Does Oliza Work?

Olanzapine belongs to class of medications known as atypical or second-generation antipsychotic drugs which are used to treat various mental illnesses such as schizophrenia, manic episodes of bipolar disorder, and depression.
Olanzapine, an atypical (second-generation) antipsychotic, primarily works by interacting with dopamine and serotonin receptors in the brain. It acts as an antagonist at dopamine D2 receptors in the mesolimbic pathway, preventing dopamine from binding and potentially affecting post-synaptic receptors. Additionally, olanzapine antagonizes serotonin 5HT2A receptors in the frontal cortex. By blocking these receptors, olanzapine helps reduce symptoms of schizophrenia, such as hallucinations and delusions.

Storage Instructions for Oliza Tablets

Store Oliza tablets at controlled room temperature (20°C to 25°C), protected from heat, moisture, and sunlight. Excursions are permitted from 15°C to 30°C.
Retain the original packing of the medication and do not consume Olanzapine tablets (Oliza) beyond its expiration date printed on the blister pack. Keep the pack of Generic Olanzapine tablets away from the reach of children and pets. Do not discard Olanzapine tablets along with domestic waste or sewage. Consult your doctor or pharmacist about the correct method of disposal.

Contraindications

Oliza tablets are contraindicated in patients with a known hypersensitivity to Olanzapine or any inactive ingredient present in Oliza tablets.

Overdose

In premarketing trials involving more than 3100 patients and/or normal subjects, accidental or intentional acute overdosage of olanzapine was identified in 67 patients. In the patient taking the largest identified amount, 300 mg, the only symptoms reported were drowsiness and slurred speech. In the limited number of patients who were evaluated in hospitals, including the patient taking 300 mg, there were no observations indicating an adverse change in laboratory analytes or ECG. Vital signs were usually within normal limits following overdoses.
In postmarketing reports of overdose with olanzapine alone, symptoms have been reported in the majority of cases. In symptomatic patients, symptoms with =10% incidence included agitation/aggressiveness, dysarthria, tachycardia, various extrapyramidal symptoms, and reduced level of consciousness ranging from sedation to coma.

Warnings and Precautions to be taken when using Olanzapine Tablets

Elderly Patients with Dementia-Related Psychosis:
Increased risk of death and increased incidence of cerebrovascular adverse events (e.g., stroke, transient ischemic attack).
Suicide:
The possibility of a suicide attempt is inherent in schizophrenia and in bipolar I disorder, and close supervision of high-risk patients should accompany drug therapy; when using in combination with Fluoxetine.
Neuroleptic Malignant Syndrome:
Manage with immediate discontinuation and close monitoring
Hyperglycemia:
In some cases extreme and associated with ketoacidosis or hyperosmolar coma or death, has been reported in patients taking olanzapine. Patients taking olanzapine should be monitored for symptoms of hyperglycemia and undergo fasting blood glucose testing at the beginning of, and periodically during, treatment.
Hyperlipidemia:
Undesirable alterations in lipids have been observed. Appropriate clinical monitoring is recommended, including fasting blood lipid testing at the beginning of, and periodically during, treatment.
Weight Gain:
Potential consequences of weight gain should be considered. Patients should receive regular monitoring of weight.
Tardive Dyskinesia:
Discontinue if clinically appropriate.
Orthostatic Hypotension:
Orthostatic hypotension associated with dizziness, tachycardia, bradycardia and, in some patients, syncope, may occur especially during initial dose titration. Use caution in patients with cardiovascular disease, cerebrovascular disease, and those conditions that could affect hemodynamic responses.
Leukopenia, Neutropenia, and Agranulocytosis:
Has been reported with antipsychotics, including Olanzapine tablets. Patients with a history of a clinically significant low white blood cell count (WBC) or drug induced leukopenia/neutropenia should have their complete blood count (CBC) monitored frequently during the first few months of therapy and discontinuation of Oliza should be considered at the first sign of a clinically significant decline in WBC in the absence of other causative factors.
Seizures
: Use cautiously in patients with a history of seizures or with conditions that potentially lower the seizure threshold.
Potential for Cognitive and Motor Impairment:
Has potential to impair judgment, thinking, and motor skills. Use caution when operating machinery.
Hyperprolactinemia:
May elevate prolactin levels.

Laboratory Tests: Monitor fasting blood glucose and lipid profiles at the beginning of, and periodically during, treatment
Olanzapine Interactions
Before beginning the oral therapy of Oliza tablets, please tell your doctor about all your present medications including prescription drugs, over the counter medications, mineral supplements, herbal products, and vitamins. Generic Olanzapine tablets are known to have drug interactions with certain other medications. Please inform your doctor if you are taking Tramadol; heart or blood pressure medication (Alpha-blockers (eg, doxazosin), diazepam); carbamazepine (Carbatrol, Tegretol), HIV protease inhibitors (eg, ritonavir), omeprazole, or rifampin; fluoxetine and olanzapine (Symbyax); Anticholinergics (eg, scopolamine), benzodiazepines (eg, lorazepam), or fluvoxamine (Luvox); Dopamine receptor agonists (eg, pramipexole) or levodopa (Sinemet, Larodopa, Atamet), selegiline (Eldepryl, Emsam, Zelapar), pramipexole (Mirapex), ropinirole (Requip), and others.
Olanzapine Tablets and Alcohol
Avoid or limit the consumption of alcohol during the treatment with Generic Olanzapine tablets (Oliza tablets) because it may increase the risk of certain side effects such as dizziness, drowsiness, lightheadedness, and fainting.
Olanzapine Tablets - Driving and Other Activities
Olanzapine tablets may make you light-headed or impair your vision. Avoid activities such as driving, using machinery, or performing any activity that requires complete vigilance or perfect vision until you are sure about your safety.
Live Vaccinations, Surgery and Regular Medical Tests
If you plan to have live vaccinations, surgery or any dental procedure, inform your doctor, anesthetist, or dentist about your course of Olanzapine tablets. In case of an emergency medical treatment, please inform the practitioner about your course of Olanzapine tablets and the details of your last dose.

Side Effects of Oliza Tablets

Most common side effects have been reported during the course of treatment with Olanzapine tablets with an incidence rate of greater than 5% and at least twice that for placebo:
Oral Olanzapine Monotherapy:
Schizophrenia (Adults) – postural hypotension, constipation, weight gain, dizziness, personality disorder, akathisia
Schizophrenia (Adolescents) – sedation, weight increased, headache, increased appetite, dizziness, abdominal pain, pain in extremity, fatigue, dry mouth
Inform your doctor immediately if you experience any of these side effects. This is not an exhaustive list of all the potential side effects of Oliza tablets. Please contact your doctor immediately in case you develop any other medical conditions during the course of treatment with Olanzapine tablets.

Olanzapine Tablets during Pregnancy and Breastfeeding

Olanzapine has been classified by the US FDA as Pregnancy Category C.
The administration of Oliza Tablets especially during the last trimester of pregnancy may result in uncontrolled muscle movements or withdrawal symptoms in the newborn such as shaking, muscle stiffness and/or weakness, sleepiness, agitation, breathing problems, and difficulty in feeding. Women should completely avoid taking Olanzapine tablets during pregnancy. Small amounts of Olanzapine is transmitted to a baby through breastmilk and may result in adverse effects on the feeding child. Nursing mothers should avoid nursing an infant during the course of Oliza tablets.
Do not use this medicine without your doctor's consent in case you are pregnant. Stop using this medication and inform your doctor immediately if you become pregnant during treatment.

Buy Olanzapine 2.5 mg, 5 mg, 7.5 mg and 10 mg Pills Online From Only $0.28 per Pill

You can buy Olanzapine Tablets online from Everest Online Pharmacy at a cheap price. Oliza 2.5 mg, 5 mg, 7.5 mg and 10 mg pills, manufactured by Intas Pharmaceuticals Ltd., India are supplied in a blister strip of 10 tablets. The 2.5 mg tablets cost only $0.28 per unit when you place an order for 200 tablets.

Disclaimer

The above information is provided to the best of our knowledge and in good faith. It is without a warrant of any kind, expressed or implied.

Shipping Restriction